Your browser doesn't support javascript.
loading
Is the presence of antiphospholipid antibodies a poor prognostic factor for patients with hemolysis, elevated liver enzymes, and low platelet count syndrome?
Pécourt, Mathilde; Yelnik, Cécile; Ghesquiere, Louise; Drumez, Élodie; Cailliau, Émeline; Hachulla, Éric; Debarge, Véronique; Morel, Nathalie; Le Guern, Véronique; Garabedian, Charles; Costedoat-Chalumeau, Nathalie; Lambert, Marc.
Affiliation
  • Pécourt M; Vascular Medicine Department, Groupe Hospitalier Paris Saint-Joseph, Paris, France. Electronic address: mathilde.pecourt@gmail.com.
  • Yelnik C; Internal Medicine and Clinical Immunology Department, Reference Center for Rare Systemic Autoimminue Diseases of North and Northwest France (CeRAINO), European Reference Network on Rare Connective Tissues and Musculoskeletal Diseases (ReCONNECT), Centre Hospitalier Universitaire de Lille, Lille, Fra
  • Ghesquiere L; Gynecology-Obstetrics Department, Centre Hospitalier Universitaire de Lille, Lille, France.
  • Drumez É; ULR 2694 Metrics Evaluation of Health Techonologies and Medical Practices Unit, Biostatistics Department, Centre Hospitalier Universitaire de Lille, Lille, France.
  • Cailliau É; ULR 2694 Metrics Evaluation of Health Techonologies and Medical Practices Unit, Biostatistics Department, Centre Hospitalier Universitaire de Lille, Lille, France.
  • Hachulla É; Internal Medicine and Clinical Immunology Department, Reference Center for Rare Systemic Autoimminue Diseases of North and Northwest France (CeRAINO), European Reference Network on Rare Connective Tissues and Musculoskeletal Diseases (ReCONNECT), Centre Hospitalier Universitaire de Lille, Lille, Fra
  • Debarge V; Gynecology-Obstetrics Department, Centre Hospitalier Universitaire de Lille, Lille, France.
  • Morel N; INSERM U1153, Internal Medicine Service, Reference Center for Rare Systemic Autoimminue Diseases, Hôpital Cochin, Université de Paris, Paris, France.
  • Le Guern V; INSERM U1153, Internal Medicine Service, Reference Center for Rare Systemic Autoimminue Diseases, Hôpital Cochin, Université de Paris, Paris, France.
  • Garabedian C; Gynecology-Obstetrics Department, Centre Hospitalier Universitaire de Lille, Lille, France.
  • Costedoat-Chalumeau N; INSERM U1153, Internal Medicine Service, Reference Center for Rare Systemic Autoimminue Diseases, Hôpital Cochin, Université de Paris, Paris, France.
  • Lambert M; Internal Medicine and Clinical Immunology Department, Reference Center for Rare Systemic Autoimminue Diseases of North and Northwest France (CeRAINO), European Reference Network on Rare Connective Tissues and Musculoskeletal Diseases (ReCONNECT), Centre Hospitalier Universitaire de Lille, Lille, Fra
Am J Obstet Gynecol ; 225(4): 432.e1-432.e7, 2021 10.
Article in En | MEDLINE | ID: mdl-33812811
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Abortion, Induced / Antiphospholipid Syndrome / HELLP Syndrome / Antibodies, Antiphospholipid / Abortion, Therapeutic / Premature Birth / Live Birth Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Am J Obstet Gynecol Year: 2021 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Abortion, Induced / Antiphospholipid Syndrome / HELLP Syndrome / Antibodies, Antiphospholipid / Abortion, Therapeutic / Premature Birth / Live Birth Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Am J Obstet Gynecol Year: 2021 Document type: Article Country of publication: Estados Unidos